Andrews Paul L R, Horn Charles C
Division of Basic Medical Sciences, St George's University of London, Cranmer Terrace, London, SW 17 0RE, UK.
Auton Neurosci. 2006 Apr 30;125(1-2):100-15. doi: 10.1016/j.autneu.2006.01.008. Epub 2006 Mar 23.
Nausea and vomiting are amongst the most common symptoms encountered in medicine as either symptoms of diseases or side effects of treatments. In a more biological setting they are also important components of an organism's defences against ingested toxins. Identification of treatments for nausea and vomiting and reduction of emetic liability of new therapies has largely relied on the use of animal models, and although such models have proven invaluable in identification of the anti-emetic effects of both 5-hydroxytryptamine(3) and neurokinin(1) receptor antagonists selection of appropriate models is still a matter of debate. The present paper focuses on a number of controversial issues and gaps in our knowledge in the study of the physiology of nausea and vomiting including: The choice of species for the study of emesis and the underlying behavioural (e.g. neophobia), anatomical (e.g. elongated, narrow abdominal oesophagus with reduced ability to shorten) and physiological (e.g. brainstem circuitry) mechanisms that explain the lack of a vomiting reflex in certain species (e.g. rats); The choice of response to measure (emesis[retching and vomiting], conditioned flavour avoidance or aversion, ingestion of clay[pica], plasma hormone levels[e.g. vasopressin], gastric dysrhythmias) and the relationship of these responses to those observed in humans and especially to the sensation of nausea; The stimulus coding of nausea and emesis by abdominal visceral afferents and especially the vagus-how do the afferents encode information for normal postprandial sensations, nausea and finally vomiting?; Understanding the central processing of signals for nausea and vomiting is particularly problematic in the light of observations that vomiting is more readily amenable to pharmacological treatment than is nausea, despite the assumption that nausea represents "low" intensity activation of pathways that can evoke vomiting when stimulated more intensely.
恶心和呕吐是医学中最常见的症状,既可以是疾病的症状,也可以是治疗的副作用。在更具生物学背景的情况下,它们也是生物体抵御摄入毒素的重要组成部分。恶心和呕吐治疗方法的确定以及新疗法催吐风险的降低在很大程度上依赖于动物模型的使用,尽管这些模型在确定5-羟色胺(3)和神经激肽(1)受体拮抗剂的抗呕吐作用方面已被证明具有极高价值,但合适模型的选择仍然存在争议。本文重点关注恶心和呕吐生理学研究中一些有争议的问题以及我们知识上的空白,包括:用于呕吐研究的物种选择以及解释某些物种(如大鼠)缺乏呕吐反射的潜在行为(如新事物恐惧症)、解剖学(如食管细长且狭窄,缩短能力降低)和生理学(如脑干神经回路)机制;用于测量的反应选择(呕吐[干呕和呕吐]、条件性味觉回避或厌恶、食土癖[异食癖]、血浆激素水平[如血管加压素]、胃节律紊乱)以及这些反应与人类观察到的反应,尤其是与恶心感觉之间的关系;腹部内脏传入神经,尤其是迷走神经对恶心和呕吐的刺激编码——传入神经如何编码正常餐后感觉、恶心以及最终呕吐的信息?;鉴于尽管人们认为恶心代表了在更强烈刺激时可引发呕吐的通路的“低”强度激活,但呕吐比恶心更容易接受药物治疗,因此理解恶心和呕吐信号的中枢处理尤其具有挑战性。